| NCT ID | NCT06342453 |
| Status | Recruiting |
| Phase | — |
| Sponsor | OHSU Knight Cancer Institute |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2024-06-04 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2024-06-04 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos can affect symptoms and impact the quality of life in children with cancer. Creative arts mind-body interventions (CrA) are one type of complementary health interventions which have been associated with improved quality of life and reduced symptom burden among children with cancer. CrA is an ideal intervention for children with cancer due to the long hours spent in the hospital setting for treatments, the creativity and developmental focus of children, and their potential ability to communicate more easily through art than words. Researchers want to develop and test a CrA intervention to help improve symptoms and the quality of life of children with cancer.
Eligibility Criteria
Inclusion Criteria: * Aged 8 to 13 years of age * Have been diagnosed with cancer of any type in the prior 12 months * Be English literate (we will amend this criterium when the study surveys are validated in Spanish). Parent/caregiver of child participant may be Spanish speaking * Physically and cognitively able to participate in creative arts * Expected to receive enough treatment at local site to participate in all four intervention sessions Exclusion Criteria: * Not English literate * Otherwise unable to complete study procedures
Contact & Investigator
Jennifer L Raybin
PRINCIPAL INVESTIGATOR
OHSU Knight Cancer Institute
Frequently Asked Questions
Who can join the NCT06342453 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 13 Years, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06342453 currently recruiting?
Yes, NCT06342453 is actively recruiting participants. Contact the research team at jordanju@ohsu.edu for enrollment information.
Where is the NCT06342453 trial being conducted?
This trial is being conducted at Portland, United States.
Who is sponsoring the NCT06342453 clinical trial?
NCT06342453 is sponsored by OHSU Knight Cancer Institute. The principal investigator is Jennifer L Raybin at OHSU Knight Cancer Institute. The trial plans to enroll 72 participants.